SPONSOR
The Netherlands Cancer Institute
Total Trials
3
Recruiting
3
Phases
Phase 3, Phase 2
Conditions studied: Radiation NecrosisHigh Grade Glioma (III or IV)Brain MetastasasesRadiation ToxicityRadiation EffectRadiation InjuryRadiation InjuriesHER2-positive Breast CancerSecond CancerSurvivorship
The Netherlands Cancer Institute is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Radiation Necrosis, High Grade Glioma (III or IV), Brain Metastasases, Radiation Toxicity.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The Netherlands Cancer Institute
How many clinical trials has The Netherlands Cancer Institute sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by The Netherlands Cancer Institute, of which 3 are actively recruiting participants. These trials cover conditions including Radiation Necrosis, High Grade Glioma (III or IV), Brain Metastasases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The Netherlands Cancer Institute research focus on?
The Netherlands Cancer Institute clinical trials span Radiation Necrosis, High Grade Glioma (III or IV), Brain Metastasases, Radiation Toxicity, Radiation Effect, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The Netherlands Cancer Institute clinical trial?
To participate in a The Netherlands Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The Netherlands Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by The Netherlands Cancer Institute
NCT06888817 Phase 3
Recruiting
Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases
Radiation Necrosis
NCT05982678 Phase 2
Recruiting
Basket Study for Oligo-metastatic Breast Cancer
HER2-positive Breast Cancer
NCT04682470
Recruiting
The Prospective Observational COMPRAYA Cohort Study
Second Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology